[HTML][HTML] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

RR Jaeschke, E Sujkowska, M Sowa-Kućma - Psychopharmacology, 2021 - Springer
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Methylphenidate for attention-deficit/hyperactivity disorder in adults: A narrative review.

RR Jaeschke, E Sujkowska… - Psychopharmacology, 2021 - psycnet.apa.org
Rationale: Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

[PDF][PDF] Methylphenidate for attention‑deficit/hyperactivity disorder in adults: a narrative review

RR Jaeschke, E Sujkowska, M Sowa‑Kućma - Psychopharmacology, 2021 - ur.edu.pl
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

RR Jaeschke, E Sujkowska, M Sowa-Kucma - Psychopharmacology, 2021 - go.gale.com
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

[PDF][PDF] Methylphenidate for attention‑deficit/hyperactivity disorder in adults: a narrative review

RR Jaeschke, E Sujkowska, M Sowa‑Kućma - 2021 - researchgate.net
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

RR Jaeschke, E Sujkowska… - Psychopharmacology, 2021 - europepmc.org
Objective The aim of this paper is to provide an up-to-date outline of the pharmacology and
clinical utility of MPH for ADHD in adult patients. Methods While conducting the narrative …

[PDF][PDF] Methylphenidate for attention‑deficit/hyperactivity disorder in adults: a narrative review

RR Jaeschke, E Sujkowska… - …, 2021 - portalwiedzy.cm-uj.krakow.pl
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

RR Jaeschke, E Sujkowska… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …

[引用][C] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

R Jaeschke, E Sujkowska, M Sowa-Kućma - Psychopharmacology, 2021 - ruj.uj.edu.pl
Methylphenidate for attention-deficit/hyperactivity disorder in adults : a narrative review Przejdź
do treści Pomoc A A A Zmień kontrast Zaloguj English polski   Repozytorium Uniwersytetu …

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

RR Jaeschke, E Sujkowska… - …, 2021 - search.ebscohost.com
Rationale: Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …